Literature DB >> 10049823

A novel Vpr peptide interactor fused to integrase (IN) restores integration activity to IN-defective HIV-1 virions.

J Kulkosky1, M BouHamdan, A Geist, R J Pomerantz.   

Abstract

A novel approach to complement human immunodeficiency virus type I (HIV-1) integrase (IN)-defective virions has been identified. The approach involves fusion of a 23-amino-acid stretch to the N-terminus of wild-type IN and coexpression of this chimera with the IN-defective proviral template in virus producing cells. The 23-amino-acid peptide represents a Vpr "interactor," referred to as the the WxxF or WF domain, which apparently leads to docking of the domain along with the fusion partner onto HIV-1 Vpr, thus permitting virion incorporation of the chimeric protein when expressed, in trans, with other viral products. Transfection of the WF-IN expression plasmid along with HIV-1 viral clones that produce Vpr, but bear an IN mutation, results in the release of a proportion of viral particles that are competent for integration. The extent of complementation was assessed using the MAGI cell assay, where integration of viral DNA results in the eventual appearance of easily visible multinucleated blue syncytia. The efficiency of dWF-IN (double copy of WF domain) complementation is not improved markedly by incorporation of a HIV-1 protease cleavage site (PR) between the dWF domain and IN (dWF-PR-IN), unlike that observed with Vpr fusions to IN. Furthermore, the ability of Vpr-PR-IN and dWF-PR-IN to complement IN-defective proviral clones, both of which bear an intervening protease cleavage site, appear comparable. Western blotting analyses using virions isolated through sucrose cushions demonstrate clearly the incorporation of the dWF-IN fusion protein into Vpr containing HIV-1 particles but not in Vpr-deficient virions. Additional Western blotting analyses indicate that all Vpr-IN and dWF-IN chimeras, with or without a PR site, are packaged into virions. The efficiency of virion incorporation of Vpr-IN and dWF-IN chimeras appears approximately comparable by Western blotting analysis. The ability of dWF-IN to complement IN-defective proviruses with efficiency similar to that of Vpr-PR-IN and dWF-PR-IN indicates that dWF-IN retains the full complement of functions necessary for integration of proviral DNA and is likely due to the benign nature of this small domain at the amino-terminus of IN. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10049823     DOI: 10.1006/viro.1998.9544

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  7 in total

1.  Disulfide-linked integrase oligomers involving C280 residues are formed in vitro and in vivo but are not essential for human immunodeficiency virus replication.

Authors:  Julien Bischerour; Hervé Leh; Eric Deprez; Jean-Claude Brochon; Jean-François Mouscadet
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

2.  Partial rescue of the Vif-negative phenotype of mutant human immunodeficiency virus type 1 strains from nonpermissive cells by intravirion reverse transcription.

Authors:  G Dornadula; S Yang; R J Pomerantz; H Zhang
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

3.  HIV-1 Integrase Binds the Viral RNA Genome and Is Essential during Virion Morphogenesis.

Authors:  Jacques J Kessl; Sebla B Kutluay; Dana Townsend; Stephanie Rebensburg; Alison Slaughter; Ross C Larue; Nikoloz Shkriabai; Nordine Bakouche; James R Fuchs; Paul D Bieniasz; Mamuka Kvaratskhelia
Journal:  Cell       Date:  2016-08-25       Impact factor: 41.582

4.  The HIV-1 protein Vpr targets the endoribonuclease Dicer for proteasomal degradation to boost macrophage infection.

Authors:  Laurieann Casey Klockow; Hamayun J Sharifi; Xiaoyun Wen; Meg Flagg; Andrea K M Furuya; Michael Nekorchuk; Carlos M C de Noronha
Journal:  Virology       Date:  2013-07-09       Impact factor: 3.616

5.  Inhibition of HIV-1 Viral Infection by an Engineered CRISPR Csy4 RNA Endoribonuclease.

Authors:  Rui Guo; Hong Wang; Jiuwei Cui; Guanjun Wang; Wei Li; Ji-Fan Hu
Journal:  PLoS One       Date:  2015-10-23       Impact factor: 3.240

6.  Defining the interactions and role of DCAF1/VPRBP in the DDB1-cullin4A E3 ubiquitin ligase complex engaged by HIV-1 Vpr to induce a G2 cell cycle arrest.

Authors:  Francine C A Gérard; Ruifeng Yang; Bizhan Romani; Alexis Poisson; Jean-Philippe Belzile; Nicole Rougeau; Éric A Cohen
Journal:  PLoS One       Date:  2014-02-18       Impact factor: 3.240

7.  Driving DNA transposition by lentiviral protein transduction.

Authors:  Yujia Cai; Jacob Giehm Mikkelsen
Journal:  Mob Genet Elements       Date:  2014-06-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.